These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
403 related articles for article (PubMed ID: 14505276)
21. From the Centers for Disease Control and Prevention. Update: investigation of bioterrorism-related inhalation anthrax--Connecticut, 2001. JAMA; 2001 Dec; 286(23):2936-7. PubMed ID: 11787482 [No Abstract] [Full Text] [Related]
22. Update: Investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(43):941-8. PubMed ID: 11708591 [TBL] [Abstract][Full Text] [Related]
23. Human anthrax as a re-emerging disease. Doganay M; Demiraslan H Recent Pat Antiinfect Drug Discov; 2015; 10(1):10-29. PubMed ID: 25851429 [TBL] [Abstract][Full Text] [Related]
24. Anthrax: ENT manifestations and current concepts. Wirtschafter A; Cherukuri S; Benninger MS Otolaryngol Head Neck Surg; 2002 Jan; 126(1):8-13. PubMed ID: 11821758 [TBL] [Abstract][Full Text] [Related]
25. No evidence of a mild form of inhalational Bacillus anthracis infection during a bioterrorism-related inhalational anthrax outbreak in Washington, D.C., in 2001. Baggett HC; Rhodes JC; Fridkin SK; Quinn CP; Hageman JC; Friedman CR; Dykewicz CA; Semenova VA; Romero-Steiner S; Elie CM; Jernigan JA Clin Infect Dis; 2005 Oct; 41(7):991-7. PubMed ID: 16142664 [TBL] [Abstract][Full Text] [Related]
33. Anthrax infection. Sweeney DA; Hicks CW; Cui X; Li Y; Eichacker PQ Am J Respir Crit Care Med; 2011 Dec; 184(12):1333-41. PubMed ID: 21852539 [TBL] [Abstract][Full Text] [Related]
34. From the Centers for Disease Control and Prevention. Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001. JAMA; 2001 Nov; 286(18):2226-32. PubMed ID: 11757528 [No Abstract] [Full Text] [Related]
35. Inhalational anthrax after bioterrorism exposure: spectrum of imaging findings in two surviving patients. Earls JP; Cerva D; Berman E; Rosenthal J; Fatteh N; Wolfe PP; Clayton R; Murphy C; Pauze D; Mayer T; Bersoff-Matcha S; Urban B Radiology; 2002 Feb; 222(2):305-12. PubMed ID: 11818592 [TBL] [Abstract][Full Text] [Related]
37. Cutaneous anthrax: an overview. Celia F Dermatol Nurs; 2002 Apr; 14(2):89-92. PubMed ID: 12017087 [TBL] [Abstract][Full Text] [Related]
38. From the Centers for Disease Control and Prevention. Investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax. Centers for Disease Control and Prevention JAMA; 2001 Nov; 286(19):2392-6. PubMed ID: 11759667 [No Abstract] [Full Text] [Related]
39. Historical evolution of human anthrax from occupational disease to potentially global threat as bioweapon. D'Amelio E; Gentile B; Lista F; D'Amelio R Environ Int; 2015 Dec; 85():133-46. PubMed ID: 26386727 [TBL] [Abstract][Full Text] [Related]
40. Zoonosis update. Anthrax. Shadomy SV; Smith TL J Am Vet Med Assoc; 2008 Jul; 233(1):63-72. PubMed ID: 18593313 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]